Gene · 1871
Papers3,808
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,808
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A review on the role of LINC00467 in the carcinogenesis. | Cancer Cell Int | 2022 | 36229833 | PubTator, text mining | PubMed |
| LINC00467: an oncogenic long noncoding RNA. | Cancer Cell Int | 2022 | 36203193 | PubTator, text mining | PubMed |
| Antiproliferative effects of dried Moringa oleifera leaf extract on human Wharton's Jelly mesenchymal stem cells. | PLoS One | 2022 | 36197921 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and pathogenesis in neutrophil-predominant severe asthma: A comprehensive bioinformatics analysis. | Medicine (Baltimore) | 2022 | 36197221 | PubTator, text mining | PubMed |
| Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. | Front Immunol | 2022 | 36189286 | PubTator, text mining | PubMed |
| Hsa_hsa_circ_0081069 promotes the progression of colorectal cancer through sponging miR-665 and regulating E2F3 expression. | J Clin Lab Anal | 2022 | 36181281 | PubTator, text mining | PubMed |
| Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with FANCA mutation: A case report. | Medicine (Baltimore) | 2022 | 36181052 | PubTator, text mining | PubMed |
| Implication of non-coding RNA-mediated ROCK1 regulation in various diseases. | Front Mol Biosci | 2022 | 36177350 | PubTator, text mining | PubMed |
| An overview of resistance to chemotherapy in osteosarcoma and future perspectives. | Cancer Drug Resist | 2022 | 36176756 | PubTator, text mining | PubMed |
| Valeric acid acts as a novel HDAC3 inhibitor against prostate cancer. | Med Oncol | 2022 | 36175803 | PubTator, text mining | PubMed |
| Comprehensive bioinformatics analysis of the E2F family in human clear cell renal cell carcinoma. | Oncol Lett | 2022 | 36168311 | PubTator, text mining | PubMed |
| Exploratory genomic analysis of high-grade neuroendocrine neoplasms across diverse primary sites. | Endocr Relat Cancer | 2022 | 36165930 | PubTator, text mining | PubMed |
| Aurora Kinases as Therapeutic Targets in Head and Neck Cancer. | Cancer J | 2022 | 36165728 | PubTator, text mining | PubMed |
| Inhibition and potential treatment of colorectal cancer by natural compounds via various signaling pathways. | Front Oncol | 2022 | 36158694 | PubTator, text mining | PubMed |
| A comprehensive review on miR-153: Mechanistic and controversial roles of miR-153 in tumorigenicity of cancer cells. | Front Oncol | 2022 | 36158686 | PubTator, text mining | PubMed |
| The role of miR-200 family in the regulation of hallmarks of cancer. | Front Oncol | 2022 | 36158660 | PubTator, text mining | PubMed |
| Assessment of circulating levels of microRNA-326, microRNA-424, and microRNA-511 as biomarkers for hepatocellular carcinoma in Egyptians. | World J Hepatol | 2022 | 36157872 | PubTator, text mining | PubMed |
| Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies. | Int J Biol Sci | 2022 | 36147461 | PubTator, text mining | PubMed |
| Deciphering the Biological Effects of Radiotherapy in Cancer Cells. | Biomolecules | 2022 | 36139006 | PubTator, text mining | PubMed |
| The role of CircRNA/miRNA/mRNA axis in breast cancer drug resistance. | Front Oncol | 2022 | 36132137 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1871/papers?page=27